Logo-ps
Review COVID-19

The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis
Leila Nikniaz ORCID, Mohammad Amin Akbarzadeh ORCID, Hossein Hosseinifard ORCID, Mohammad-Salar Hosseini* ORCID
Pharm Sci. 2021;27(Suppl 1): S1-S12. doi: 10.34172/PS.2021.13
Article logoArticle
PDFPDF
Supplementary 1Suppl 1
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Review COVID-19

Anti-Rheumatic Drugs as Potential Anti-inflammatory, Immunomodulatory Agents against COVID-19: A Systematic Review
Reza Sinaei ORCID, Sara Pezeshki* ORCID, Ali Asadipour ORCID, Reza Shiari ORCID, Roya Sinaei ORCID, Ali Sinaei ORCID
Pharm Sci. 2021;27(Suppl 1): S13-S28. doi: 10.34172/PS.2021.40
Article logoArticle
PDFPDF
Supplementary 1Suppl 1
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Review COVID-19

Potential Roles of Vitamins in the Management of COVID-19: A Comprehensive Review
Homa Rezaei ORCID, Sajad Khiali ORCID, Hadis Rezaei, Haleh Rezaee, Hossein Bannazadeh Baghi, Matin Pourghasem, Taher Entezari-Maleki* ORCID
Pharm Sci. 2021;27(Suppl 1): S29-S49. doi: 10.34172/PS.2021.41
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Review COVID-19

The Clinical Characteristics and Treatment Approaches of COVID-19:A Concise Review
Sajjad Eslamkhah, Nazila Alizadeh, Khalil Hajiasgharzadeh, Masoud Eslamkhah, Ahad Mokhtarzadeh, Behzad Baradaran* ORCID
Pharm Sci. 2021;27(Suppl 1): S50-S67. doi: 10.34172/PS.2021.6
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Review COVID-19

Acyclovir as a Potential Add-on Therapy in COVID-19 Treatment Regimens
Fatemeh Heidary* ORCID, Sedigheh Madani, Reza Gharebaghi* ORCID, Fahimeh Asadi-amoli
Pharm Sci. 2021;27(Suppl 1): S68-S77. doi: 10.34172/PS.2021.38
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Mini Review COVID-19

A New Possible Indication of Direct-acting Anti-hepatitis C Drugs in the Therapeutic Management of COVID-19: A Narrative Literature Review
Alireza Mashhadi Hemmatabadi ORCID, Fatemeh Jafari ORCID, Hesamoddin Hosseinjani* ORCID
Pharm Sci. 2021;27(Suppl 1): S78-S85. doi: 10.34172/PS.2021.23
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Mini Review COVID-19

Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 Patients
Saeid Safari* ORCID, Alireza Jahangirifard, Alireza Zali, Alireza Salimi, Ehsan Bastanhagh, Reza Aminnejad, Reza Jalili Khoshnood, Davood Ommi
Pharm Sci. 2021;27(Suppl 1): S86-S93. doi: 10.34172/PS.2021.26
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Research Article COVID-19

The Integration of Pharmacophore-Based 3D-QSAR Modeling and Virtual Screening in Identification of Natural Product Inhibitors against SARS-CoV-2
Samira Norouzi, Maryam Farahani, Samad Nejad Ebrahimi* ORCID
Pharm Sci. 2021;27(Suppl 1): S94-S108. doi: 10.34172/PS.2020.98
Article logoArticle
PDFPDF
Supplementary 1Suppl 1
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Research Article COVID-19

Molecular Docking and Dynamics Simulations Reveal the Potential of Anti-HCV Drugs to Inhibit COVID-19 Main Protease
Ahmed Ali Al-Karmalawy* ORCID, Radwan Alnajjar, Mohammed Dahab, Ahmed Metwaly, Ibrahim Eissa
Pharm Sci. 2021;27(Suppl 1): S109-S121. doi: 10.34172/PS.2021.3
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Research Article COVID-19

Qualitative and Quantitative Analysis of Anti-viral Compounds against SARS-CoV-2 Protease Enzyme by Molecular Dynamics Simulation and MM/PBSA Method
Saghi Sepehri* ORCID, Niloufar Hashemidanesh, Karim Mahnam, Hila Asham
Pharm Sci. 2021;27(Suppl 1): S122-S134. doi: 10.34172/PS.2021.4
Article logoArticle
PDFPDF
Supplementary 1Suppl 1
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract
Research Article COVID-19

Natural Products as Inhibitors of COVID-19 Main Protease – A Virtual Screening by Molecular Docking
Marzieh Omrani, Mohammad Bayati, Parvaneh Mehrbod* ORCID, Kamal Asmari Bardazard, Samad Nejad-Ebrahimi* ORCID
Pharm Sci. 2021;27(Suppl 1): S135-S148. doi: 10.34172/PS.2021.11
Article logoArticle
PDFPDF
Supplementary 1Suppl 1
Supplementary 2Suppl 2
XMLXML
Cited By:
CitedBy CrossRef 0
Graphical Abstract

Indexing & Abstracting:

   

 

    

 

Director-in-Charge:
Prof. Parvin Zakeri-Milani



Follower of ICMJE

Powered by: